In MM multicellular spheroids and MM tumor fragment spheroids, the role of mTOR in mediating survival signals has been assessed in two in vitro clinically relevant three-dimensional settings, suggesting that inhibition of mTOR may provide a valid nontoxic therapy for MM [58,59]. This evidence concerns the gene MTOR and Miyoshi myopathy.